CRISPR’s Breakthrough: Targeting Undruggable Cancers with Precision
Explore CRISPR’s groundbreaking potential in targeting historically untreatable cancers, revealing transformative treatment avenues.
oncology
Thomas Seyfried’s Cancer Research: Are We Treating the Wrong Disease?
Thomas Seyfried suggests cancer may primarily stem from metabolic dysfunction, not just genetics. This challenges the existing treatment paradigm.